MagneGas Invited to United Nations Ebola Crisis Response MeetingMagneGas Corporation ("MagneGas" or the "Company") (NASDAQ: MNGA), a technology company that counts among its inventions a patented process that converts liquid waste into a hydrogen-based fuel, announced today that it has been invited to participate at the United Nations Ebola Crisis Response high-level meetings being held on Thursday, December 11, 2014 at the United Nations headquarters in New York City.
The meetings are being held by the United Nations Global Compact, the United Nations Mission for Ebola Emergency Response ("UNMEER"), and the Ebola Private Sector Mobilization Group. This assembly consists of a coalition of over 35 companies with major assets and operations in West Africa mobilizing business resources to support front-line Ebola humanitarian relief efforts while also advocating for a more concerted global response to the Ebola outbreak and recovery.
The Company will be discussing the potential use of the MagneGas technology to treat medical waste and sewage related to the Ebola outbreak in West Africa. MagneGas believes, based on past successful sterilization of highly contaminated liquid waste, that the high temperature of the Plasma Arc system will fully sterilize bio-contaminated human waste. In addition, due to the extremely high flame temperature of the MagneGas® fuel, the Company believes that the use of its fuel for co-incineration with existing systems, will increase heat output and reduce emissions further sterilizing waste as an alternative treatment option. In addition, the Company also has available a trailer mounted Plasma Arc system that can be deployed quickly and operated on a local diesel generator.
"The Company has been working for many years, both in Europe and the United States, testing the use of the MagneGas technology to sterilize waste with extremely high levels of bio-contaminants. It has been demonstrated that the exposure of bio-contaminants to our 12,000F degree electric arc renders the waste fully sterilized without the need for any chemical additives or use of other methods. We believe that this process will have a similar effect on Ebola contaminated medical waste. We are honored and humbled by the opportunity to participate in these extremely important meetings that will shape the future success of the Ebola outbreak containment. Anything that we can do to help reduce the outbreak by limiting contaminant proliferation would be extremely important to the MagneGas family," stated MagneGas CEO Ermanno Santilli.